NYSE · Agricultural Production-Crops
Quote as of Oct 9, 2:31 PM ET · delayed
Fairly Valued. Our fair value estimate is USD 72.96 against a price of USD 13.27, +450% implied upside. Reasoning and scenarios are in Corteva stock: antitrust limits meet a near-term seeds spin-off.
Corteva declared USD 0.70 per share in dividends in FY2025, up 6.1% from USD 0.66 in FY2024. At USD 13.27 that is a 5.28% trailing yield. The dividend took 44% of FY2025 diluted EPS of USD 1.60.
Corteva stock has two real developments behind the headlines: a decade-long restriction on certain pesticide loyalty programs and Vylor’s planned separation. Neither headline alone explains today’s modest decline or settles the valuation.
StockLarge CapIndustrialsNo earnings notes for this company yet.
Revenue (USD, billions)
Margins (%)
Free cash flow (USD, billions)
Estimated ROIC (%)
Net debt (USD, billions)
Monetary values are in USD; revenue, FCF and net debt are in billions; EPS is per share. Missing values appear as gaps and “Not available.” Source: SEC EDGAR XBRL filings, latest restated values; quarterly cash flow derived from year-to-date figures; Q4 = fiscal year minus nine months. ROIC is NOPAT (21% tax) over debt plus equity.
| Period | Revenue | Gross % | Op % | FCF | EPS | ROIC % | Net debt |
|---|---|---|---|---|---|---|---|
| FY2018 | 14.3 | Not available | -47.6 | -1.02 | -6.76 | Not available | Not available |
| FY2019 | 13.8 | Not available | -2.28 | -0.09 | -1.28 | Not available | Not available |
| FY2020 | 14.2 | Not available | 4.75 | Not available | 0.91 | Not available | Not available |
| FY2021 | 15.7 | Not available | 15.0 | Not available | 2.37 | Not available | Not available |
| FY2022 | 17.4 | Not available | 8.17 | Not available | 1.58 | Not available | Not available |
| FY2023 | 17.2 | Not available | 6.35 | Not available | 1.03 | Not available | Not available |
| FY2024 | 16.9 | Not available | 7.54 | Not available | 1.30 | Not available | Not available |
| FY2025 | 17.4 | Not available | 9.70 | Not available | 1.60 | Not available | Not available |
Current price
USD 13.27
Fair value estimate
USD 72.96
Implied upside
+450.0%
Bear
25%USD 61
Direct equity valuation: supplied TTM EPS multiplied by an assumed P/E multiple.
The market assigns a lower multiple as uncertainty over pesticide-program economics and the post-separation business mix weighs on the earnings multiple.
Base
50%USD 73
Direct equity valuation: supplied TTM EPS multiplied by an assumed P/E multiple.
The valuation recognizes Corteva’s established agricultural businesses but applies a lower multiple than the current 51.1x TTM P/E. This is a preliminary estimate and does not separately value Vylor.
Bull
25%USD 84
Direct equity valuation: supplied TTM EPS multiplied by an assumed P/E multiple.
The market maintains a premium earnings multiple if the seed-related settlement supports intellectual-property control and the separation clarifies the value of the businesses.
No news items logged for this company yet.